Covid-19 antibody drug moves into phase 3 trials
The biotechnology company Regeneron announced the late-stage clinical trials of REGN-COV2, its investigational double antibody cocktail for the treatment and prevention of Covid-19, in a news release on Monday. Specifically … Read More
![]()

